SCHEMBL30610089

SCHEMBL30610089

COc1ccc(C(NCC(=O)O)(c2ccccc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 5/20 0.49
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
ALDH1A1 P00352 2/20 0.46
LMNA P02545 1/20 0.46
ALOX15 P16050 1/20 0.46
APEX1 P27695 1/20 0.46
MAPK1 P28482 1/20 0.46
RECQL P46063 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
KCNN4 O15554 1/20 0.46
GAA P10253 2/20 0.45
KDM4E B2RXH2 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
KCNH2 Q12809 1/20 0.45
PTGS2 P35354 1/20 0.45
F10 P00742 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14356107 1.00 KIF11 (0.49) KIF11NPC1RAB9AALDH1A1LMNA
SCHEMBL28885052 0.89 KIF11 (0.49) KIF11NPC1RAB9AALDH1A1LMNA
SCHEMBL6476023 0.89 KIF11 (0.43) KIF11NPC1RAB9AALDH1A1LMNA
SCHEMBL12762284 0.87 KCNN4 (0.48) KIF11NPC1RAB9AALDH1A1LMNA
SCHEMBL10276699 0.86 KIF11 (0.46) KIF11NPC1RAB9AALDH1A1LMNA
SCHEMBL4199968 0.84 KCNN4 (0.56) KIF11ALDH1A1ALOX15MAPK1TDP1
SCHEMBL12225852 0.82 KIF11 (0.49) KIF11ALDH1A1LMNAMAPK1KCNN4
SCHEMBL4363002 0.82 KIF11 (0.49) KIF11ALDH1A1LMNAMAPK1KCNN4
SCHEMBL3249628 0.82 KIF11 (0.43) KIF11NPC1RAB9AALDH1A1LMNA
SCHEMBL6304679 0.82 NPC1 (0.47) KIF11NPC1RAB9AALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250236633-A1 SYNTHESIS OF ISOMERICALLY PURE POLYOL-BASED PHOSPHORAMIDITES Roche Sequencing Solutions, Inc. (US) 2025-07-24 US disclosed
EP-4499655-A1 SYNTHESIS OF ISOMERICALLY PURE POLYOL-BASED PHOSPHORAMIDITES F. Hoffmann-La Roche AG (CH) 2025-02-05 EP disclosed
WO-2023186842-A1 SYNTHESIS OF ISOMERICALLY PURE POLYOL-BASED PHOSPHORAMIDITES F. HOFFMANN-LA ROCHE AG (CH) 2023-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250236633-A1 SYNTHESIS OF ISOMERICALLY PURE POLYOL-BASED PHOSPHORAMIDITES PARG, PPA1, PGM2 KIF11 2422/4885NPC1 4801/4885RAB9A 4234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.